Health Care & Life Sciences » Pharmaceuticals | Harbin Pharmaceutical Group Co. Ltd.

Harbin Pharmaceutical Group Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
17,988
16,399
15,757
14,029
11,872
10,685
Cost of Goods Sold (COGS) incl. D&A
12,858
12,080
12,019
10,470
9,001
8,008
Gross Income
5,130
4,319
3,738
3,559
2,871
2,677
SG&A Expense
4,822
3,895
2,920
2,552
2,397
2,168
EBIT
262
348
741
974
475
462
Unusual Expense
74
58
34
7
6
8
Non Operating Income/Expense
16
30
8
56
141
90
Interest Expense
18
10
11
7
22
30
Pretax Income
299
367
786
1,053
659
588
Income Tax
163
169
172
209
194
184
Equity in Affiliates
-
-
-
-
-
-
Consolidated Net Income
137
198
614
844
464
404
Net Income
169
247
580
788
407
346
Net Income After Extraordinaries
169
247
580
788
407
346
Net Income Available to Common
169
247
580
788
407
346
EPS (Basic)
0.07
0.10
0.23
0.31
0.16
0.14
Basic Shares Outstanding
2,493
2,493
2,493
2,541
2,493
2,507
EPS (Diluted)
0.07
0.10
0.23
0.31
0.16
0.14
Diluted Shares Outstanding
2,493
2,493
2,493
2,541
2,493
2,507
EBITDA
704
805
1,225
1,416
923
892
Other Operating Expense
46
76
77
33
1
48
Non-Operating Interest Income
54
56
43
37
71
41
Minority Interest Expense
32
49
34
56
57
57

About Harbin Pharmaceutical Group Co.

View Profile
Address
No. 7 Qunli Avenue
Harbin Heilongjiang 150070
China
Employees -
Website http://www.hayao.com
Updated 07/08/2019
Harbin Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, wholesale, and retail of pharmaceutical products. It pharmaceutical covers chemical raw materials, chemical agents, biological agents, Chinese medicine, and health care products. It specializes in anti-infection, cardiovascular and cerebrovascular, cold medicine, digestive system, anti-tumor drugs, and nutritional supplements.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.